Riskpilot← Back to searchSign inGet full accessGreat Matter Pharma AB
ABBankruptOrg 5590362892Economic activity was not specified by tax authority · NACE 0000Est. 20150 employees
Revenue 2021
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2021
—
0 employees
| Revenue | — | — |
| EBITDA | SEK 0 | — |
| Net profit | — | — |
| Total assets | — | — |
| Equity | — | — |
| Employees | 0 | — |
Legal name
Great Matter Pharma AB
Org number
5590362892
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
20 november 2015
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-02-28
Financial year
January – December
Company purpose
Bolaget ska beriva grundforskning för att hitta målmolekyl(er) för behandling av Alzheimers sjukdom, kapitalförvaltning samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | — | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −69 | — | — | 0 | 0 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | −69 | 0 | 0 | 0 | 0 |
| Net financials | — | — | — | — | — |
| Profit before tax | −69 | 0 | 0 | 0 | 0 |
| Tax | −0 | −0 | −0 | — | — |
| Net profit | −69 | 0 | 0 | — | — |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 1 | 27 | 27 | — | — |
| Equity | −19 | −19 | −19 | — | — |
| Long-term debt | 15 | 46 | 46 | — | — |
| Short-term debt | 5 | 0 | 0 | — | — |
| Total debt | 20 | 46 | 46 | — | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20172021
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20172021
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20172021
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-03-01 – 2021-02-28
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-03-01 – 2020-02-29
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-03-01 – 2019-02-28
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-03-01 – 2018-02-28
- Annual report 2017Filed via Bolagsverket / SCB · Period 2015-11-01 – 2017-02-28
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AK Liquidator | Liquidator | 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Chairman | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Great Matter Pharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Kerstin Bengtsson Tholander | Liquidator | 0 companies |
| Pavel Pavlov | Board of Directors | 0 companies |
| Gustavo A Montero | Board of Directors | 0 companies |
| Alexandra Carl Bernadotte | Board of Directors | 0 companies |
| Bengt Göran Winblad | Chairman | 0 companies |